Entropy Technologies LP Acquires 47,352 Shares of Bath & Body Works, Inc. $BBWI

Entropy Technologies LP raised its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 244.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 66,695 shares of the company’s stock after buying an additional 47,352 shares during the quarter. Entropy Technologies LP’s holdings in Bath & Body Works were worth $1,245,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Chase Investment Counsel Corp acquired a new stake in Bath & Body Works in the 4th quarter worth $1,606,000. SG Americas Securities LLC increased its holdings in shares of Bath & Body Works by 725.3% during the 4th quarter. SG Americas Securities LLC now owns 466,338 shares of the company’s stock worth $9,364,000 after purchasing an additional 409,831 shares during the period. Wedge Capital Management L L P NC raised its position in shares of Bath & Body Works by 49.9% during the fourth quarter. Wedge Capital Management L L P NC now owns 214,362 shares of the company’s stock valued at $4,304,000 after buying an additional 71,349 shares during the last quarter. Vaughan Nelson Investment Management L.P. raised its position in shares of Bath & Body Works by 27.4% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 2,132,245 shares of the company’s stock valued at $42,815,000 after buying an additional 458,620 shares during the last quarter. Finally, Intech Investment Management LLC lifted its stake in shares of Bath & Body Works by 462.6% in the fourth quarter. Intech Investment Management LLC now owns 108,766 shares of the company’s stock valued at $2,184,000 after buying an additional 89,432 shares during the period. 95.14% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of research firms recently weighed in on BBWI. Wells Fargo & Company lifted their target price on Bath & Body Works from $25.00 to $26.00 and gave the stock an “overweight” rating in a research report on Tuesday, June 23rd. Piper Sandler began coverage on Bath & Body Works in a report on Friday, May 15th. They issued a “neutral” rating and a $20.00 price target for the company. UBS Group reduced their price objective on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating for the company in a research report on Wednesday, May 20th. Morgan Stanley reissued an “equal weight” rating and set a $22.00 price objective on shares of Bath & Body Works in a report on Monday, July 6th. Finally, Telsey Advisory Group lowered their price objective on Bath & Body Works from $25.00 to $22.00 and set a “market perform” rating on the stock in a research report on Thursday, May 28th. Three investment analysts have rated the stock with a Buy rating, fourteen have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $22.00.

Bath & Body Works Stock Up 2.8%

NYSE:BBWI opened at $20.47 on Tuesday. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $32.32. The firm has a market capitalization of $4.13 billion, a PE ratio of 5.75, a price-to-earnings-growth ratio of 1.97 and a beta of 1.38. The firm has a 50-day moving average price of $19.90 and a 200 day moving average price of $20.43.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. During the same quarter last year, the company earned $0.49 earnings per share. The company’s revenue for the quarter was down 3.2% compared to the same quarter last year. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, research analysts expect that Bath & Body Works, Inc. will post 2.63 EPS for the current year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 19th. Shareholders of record on Friday, June 5th were paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 3.9%. The ex-dividend date was Friday, June 5th. Bath & Body Works’s dividend payout ratio is currently 22.47%.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.